New birth control implant enters early human testing
NCT ID NCT05174884
First seen Apr 11, 2026 · Last updated May 13, 2026 · Updated 6 times
Summary
This early-stage study tests a new contraceptive implant called Casea S in 20 healthy women aged 18-45. The goal is to check how the body processes the hormone, how easy it is to remove, and if it's safe. The implant aims to prevent pregnancy for at least 78 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTRACEPTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinica Profamilia
Santo Domingo, DN, 10401, Dominican Republic
Conditions
Explore the condition pages connected to this study.